SPY308.08+2.53 0.83%
DIA257.85+2.58 1.01%
IXIC9,608.38+56.33 0.59%

GW Pharmaceuticals Q2 EPS $(0.020) Beats $(0.850) Estimate, Sales $120.535M Beat $108.360M Estimate

GW Pharmaceuticals (NASDAQ:GWPH) reported quarterly losses of $(0.020) per share which beat the analyst consensus estimate of $(0.850) by 97.65 percent. This is a 85.71 percent increase over losses of $(0.140) per share

Benzinga · 05/11/2020 20:00

GW Pharmaceuticals (NASDAQ:GWPH) reported quarterly losses of $(0.020) per share which beat the analyst consensus estimate of $(0.850) by 97.65 percent. This is a 85.71 percent increase over losses of $(0.140) per share from the same period last year. The company reported quarterly sales of $120.535 million which beat the analyst consensus estimate of $108.360 million by 11.24 percent. This is a 207.12 percent increase over sales of $39.247 million the same period last year.